Consequently, the K562/ADM cell line was selected to evaluate the reversal effects of emodin on MDR in CML and to investigate whether emodin is the substrate of P-gp as well as its binding sites to P-gp. Here, PGP is linked to chronic myelogenous leukemia, BCR-ABL1 positive.